Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Profile of BNT162b2 mRNA SARS-Cov-2 Vaccine in Indonesia: A National Passive Surveillance.

NCT05621239 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05621239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Profile of BNT162b2 mRNA SARS-Cov-2 Vaccine in Indonesia: A National Passive Surveillance.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
April 3, 2023
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19